These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 24367617)

  • 1. Hepatitis C virus co-infection increases the risk of anti-tuberculosis drug-induced hepatotoxicity among patients with pulmonary tuberculosis.
    Lomtadze N; Kupreishvili L; Salakaia A; Vashakidze S; Sharvadze L; Kempker RR; Magee MJ; del Rio C; Blumberg HM
    PLoS One; 2013; 8(12):e83892. PubMed ID: 24367617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence, drug-induced hepatotoxicity, and mortality among patients multi-infected with HIV, tuberculosis, and hepatitis virus.
    Mo P; Zhu Q; Teter C; Yang R; Deng L; Yan Y; Chen J; Zeng J; Gui XE
    Int J Infect Dis; 2014 Nov; 28():95-100. PubMed ID: 25218771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B or hepatitis C co-infection in individuals infected with human immunodeficiency virus and effect of anti-tuberculosis drugs on liver function.
    Padmapriyadarsini C; Chandrabose J; Victor L; Hanna LE; Arunkumar N; Swaminathan S
    J Postgrad Med; 2006; 52(2):92-6. PubMed ID: 16679670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral hepatitis prevalence in patients with active and latent tuberculosis.
    Nooredinvand HA; Connell DW; Asgheddi M; Abdullah M; O'Donoghue M; Campbell L; Wickremasinghe MI; Lalvani A; Kon OM; Khan SA
    World J Gastroenterol; 2015 Aug; 21(29):8920-6. PubMed ID: 26269682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral hepatitis and HIV-associated tuberculosis: risk factors and TB treatment outcomes in Thailand.
    Sirinak C; Kittikraisak W; Pinjeesekikul D; Charusuntonsri P; Luanloed P; Srisuwanvilai LO; Nateniyom S; Akksilp S; Likanonsakul S; Sattayawuthipong W; Burapat C; Varma JK
    BMC Public Health; 2008 Jul; 8():245. PubMed ID: 18638392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HBV, HCV, and HBV/HCV co-infection among HIV-positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcome.
    Su S; Fairley CK; Sasadeusz J; He J; Wei X; Zeng H; Jing J; Mao L; Chen X; Zhang L
    J Med Virol; 2018 Mar; 90(3):518-525. PubMed ID: 29091279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C and not Hepatitis B virus is a risk factor for anti-tuberculosis drug induced liver injury.
    Kim WS; Lee SS; Lee CM; Kim HJ; Ha CY; Kim HJ; Kim TH; Jung WT; Lee OJ; Hong JW; You HS; Cho HC
    BMC Infect Dis; 2016 Feb; 16():50. PubMed ID: 26833347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of chronic viral hepatitis on tuberculosis treatment interruption.
    Chua AP; Lim LK; Gan SH; Chee CB; Wang YT
    Int J Tuberc Lung Dis; 2018 Dec; 22(12):1486-1494. PubMed ID: 30606322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. INCIDENCE OF TUBERCULOSIS AMONG HIV/HCV CO-INFECTED PATIENTS RECEIVING HEPATITIS C TREATMENT WITH PEGYLATED INTERFERON AND RIBAVIRIN IN GEORGIA.
    Abutidze A; Bolokadze N; Chkhartishvili N; Sharvadze L; Tsertsvadze T
    Georgian Med News; 2016 Mar; (252):10-5. PubMed ID: 27119828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low prevalence of hepatitis B and C among tuberculosis patients in Duhok Province, Kurdistan: Are HBsAg and anti-HCV prerequisite screening parameters in tuberculosis control program?
    Merza MA; Haji SM; Alsharafani AM; Muhammed SU
    Int J Mycobacteriol; 2016 Sep; 5(3):313-317. PubMed ID: 27847016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.
    Chen X; He JM; Ding LS; Zhang GQ; Zou XB; Zheng J
    Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics of hepatitis B and C virus infections in HIV-infected patients.
    Phuangchoei P; Chotiyaputta W; Chayakulkeeree M
    J Med Assoc Thai; 2015 Mar; 98(3):226-31. PubMed ID: 25920291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients.
    Otegbayo JA; Taiwo BO; Akingbola TS; Odaibo GN; Adedapo KS; Penugonda S; Adewole IF; Olaleye DO; Murphy R; Kanki P
    Ann Hepatol; 2008; 7(2):152-6. PubMed ID: 18626434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of hepatitis B virus and hepatitis C virus co-infection with human immunodeficiency virus in Thai patients: a tertiary-care-based study.
    Sungkanuparph S; Vibhagool A; Manosuthi W; Kiertiburanakul S; Atamasirikul K; Aumkhyan A; Thakkinstian A
    J Med Assoc Thai; 2004 Nov; 87(11):1349-54. PubMed ID: 15825712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and virological characteristics of hepatitis B or C virus co-infection with HIV in Indonesian patients.
    Anggorowati N; Yano Y; Heriyanto DS; Rinonce HT; Utsumi T; Mulya DP; Subronto YW; Hayashi Y
    J Med Virol; 2012 Jun; 84(6):857-65. PubMed ID: 22499006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus infection increases hepatitis risk during anti-tuberculosis treatment.
    Chien JY; Huang RM; Wang JY; Ruan SY; Chien YJ; Yu CJ; Yang PC
    Int J Tuberc Lung Dis; 2010 May; 14(5):616-21. PubMed ID: 20392356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of hepatitis B and C viruses and risk factors in HIV infected children at the Felgehiwot referral hospital, Ethiopia.
    Abera B; Zenebe Y; Mulu W; Kibret M; Kahsu G
    BMC Res Notes; 2014 Nov; 7():838. PubMed ID: 25421947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of hepatitis C virus but not HIV co-infection among patients with tuberculosis in Georgia.
    Richards DC; Mikiashvili T; Parris JJ; Kourbatova EV; Wilson JC; Shubladze N; Tsertvadze T; Khechinashvili G; del Rio C; Blumberg HM
    Int J Tuberc Lung Dis; 2006 Apr; 10(4):396-401. PubMed ID: 16602403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for HBV, HCV, HIV and syphilis infections among bacteriologically confirmed tuberculosis prisoners: An urgent action required.
    Puga MAM; Bandeira LM; Pompilio MA; Rezende GR; Soares LS; de Castro VOL; Tanaka TSO; Cesar GA; de Oliveira SMDVL; Teles SA; Yassuda RTS; Weis-Torres SMDS; Basílio SF; Croda J; Motta-Castro ARC
    PLoS One; 2019; 14(8):e0221265. PubMed ID: 31437184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-infection with hepatitis B virus among tuberculosis patients is associated with poor outcomes during anti-tuberculosis treatment.
    Chen L; Bao D; Gu L; Gu Y; Zhou L; Gao Z; Huang Y
    BMC Infect Dis; 2018 Jul; 18(1):295. PubMed ID: 29970037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.